Frank Fliegert

Frank Fliegert has a diverse work experience spanning over two decades. Frank started their career as a Physician at Hannover Medical School in 1994 and later worked as a Research Scientist at the University of Aachen. Frank then joined Grünenthal GmbH as the Deputy Head of Clinical Pharmacology and subsequently worked as a Drug Management Expert at Allianz AG. Frank then transitioned into the pharmaceutical industry, with roles at NOXXON Pharma AG, SynteractHCR GmbH, and Prima Biomed GmbH. Frank served as the VP of Clinical Drug Development at NOXXON Pharma AG and as the Clinical Pharmacology Unit Director at SynteractHCR GmbH. At Prima Biomed GmbH, they held the position of Global Medical Director. Frank's clinical expertise continued to grow as they joined medac GmbH, where they served as the Clinical Scientific Program Lead for four years. Frank then took on the role of the Senior Medical Director at Immunic Therapeutics, where they worked until 2023. Most recently, Frank has taken on the position of Director of Early Clinical Development at ITM Isotope Technologies Munich SE.

Frank Fliegert obtained their MD degree in Human Medicine from Hannover Medical School, where they studied from 1987 to 1994. Frank also holds additional certifications in clinical pharmacology from the Berlin Chamber of Physicians in 2012 and a diploma in pharmaceutical medicine from EUCOR/ECPM in 2003.